Report Detail

Pharma & Healthcare Global Famotidine for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4681794
  • |
  • 27 February, 2026
  • |
  • Global
  • |
  • 97 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Famotidine for Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Famotidine for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Famotidine for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Famotidine for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Famotidine for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Famotidine for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Famotidine for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Famotidine for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Rakshit Drugs, Gauri Fine Chemicals, PAT IMPEX, Hainan Shuangcheng Pharmaceuticals, Hikma Pharmaceuticals, Baxter Healthcare, Athenex, Mylan Pharmaceuticals, Actiza Pharmaceutical, Omega Labs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Famotidine for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
10mg/mL
20mg/mL
Market segment by Application
Hospital
Clinic
Major players covered
Rakshit Drugs
Gauri Fine Chemicals
PAT IMPEX
Hainan Shuangcheng Pharmaceuticals
Hikma Pharmaceuticals
Baxter Healthcare
Athenex
Mylan Pharmaceuticals
Actiza Pharmaceutical
Omega Labs
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Famotidine for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Famotidine for Injection, with price, sales quantity, revenue, and global market share of Famotidine for Injection from 2021 to 2026.
Chapter 3, the Famotidine for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Famotidine for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Famotidine for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Famotidine for Injection.
Chapter 14 and 15, to describe Famotidine for Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Famotidine for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 10mg/mL
    • 1.3.3 20mg/mL
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Famotidine for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Famotidine for Injection Market Size & Forecast
    • 1.5.1 Global Famotidine for Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Famotidine for Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Famotidine for Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Rakshit Drugs
    • 2.1.1 Rakshit Drugs Details
    • 2.1.2 Rakshit Drugs Major Business
    • 2.1.3 Rakshit Drugs Famotidine for Injection Product and Services
    • 2.1.4 Rakshit Drugs Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Rakshit Drugs Recent Developments/Updates
  • 2.2 Gauri Fine Chemicals
    • 2.2.1 Gauri Fine Chemicals Details
    • 2.2.2 Gauri Fine Chemicals Major Business
    • 2.2.3 Gauri Fine Chemicals Famotidine for Injection Product and Services
    • 2.2.4 Gauri Fine Chemicals Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Gauri Fine Chemicals Recent Developments/Updates
  • 2.3 PAT IMPEX
    • 2.3.1 PAT IMPEX Details
    • 2.3.2 PAT IMPEX Major Business
    • 2.3.3 PAT IMPEX Famotidine for Injection Product and Services
    • 2.3.4 PAT IMPEX Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 PAT IMPEX Recent Developments/Updates
  • 2.4 Hainan Shuangcheng Pharmaceuticals
    • 2.4.1 Hainan Shuangcheng Pharmaceuticals Details
    • 2.4.2 Hainan Shuangcheng Pharmaceuticals Major Business
    • 2.4.3 Hainan Shuangcheng Pharmaceuticals Famotidine for Injection Product and Services
    • 2.4.4 Hainan Shuangcheng Pharmaceuticals Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
  • 2.5 Hikma Pharmaceuticals
    • 2.5.1 Hikma Pharmaceuticals Details
    • 2.5.2 Hikma Pharmaceuticals Major Business
    • 2.5.3 Hikma Pharmaceuticals Famotidine for Injection Product and Services
    • 2.5.4 Hikma Pharmaceuticals Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 2.6 Baxter Healthcare
    • 2.6.1 Baxter Healthcare Details
    • 2.6.2 Baxter Healthcare Major Business
    • 2.6.3 Baxter Healthcare Famotidine for Injection Product and Services
    • 2.6.4 Baxter Healthcare Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Baxter Healthcare Recent Developments/Updates
  • 2.7 Athenex
    • 2.7.1 Athenex Details
    • 2.7.2 Athenex Major Business
    • 2.7.3 Athenex Famotidine for Injection Product and Services
    • 2.7.4 Athenex Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Athenex Recent Developments/Updates
  • 2.8 Mylan Pharmaceuticals
    • 2.8.1 Mylan Pharmaceuticals Details
    • 2.8.2 Mylan Pharmaceuticals Major Business
    • 2.8.3 Mylan Pharmaceuticals Famotidine for Injection Product and Services
    • 2.8.4 Mylan Pharmaceuticals Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Mylan Pharmaceuticals Recent Developments/Updates
  • 2.9 Actiza Pharmaceutical
    • 2.9.1 Actiza Pharmaceutical Details
    • 2.9.2 Actiza Pharmaceutical Major Business
    • 2.9.3 Actiza Pharmaceutical Famotidine for Injection Product and Services
    • 2.9.4 Actiza Pharmaceutical Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Actiza Pharmaceutical Recent Developments/Updates
  • 2.10 Omega Labs
    • 2.10.1 Omega Labs Details
    • 2.10.2 Omega Labs Major Business
    • 2.10.3 Omega Labs Famotidine for Injection Product and Services
    • 2.10.4 Omega Labs Famotidine for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Omega Labs Recent Developments/Updates

3 Competitive Environment: Famotidine for Injection by Manufacturer

  • 3.1 Global Famotidine for Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Famotidine for Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Famotidine for Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Famotidine for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Famotidine for Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Famotidine for Injection Manufacturer Market Share in 2025
  • 3.5 Famotidine for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Famotidine for Injection Market: Region Footprint
    • 3.5.2 Famotidine for Injection Market: Company Product Type Footprint
    • 3.5.3 Famotidine for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Famotidine for Injection Market Size by Region
    • 4.1.1 Global Famotidine for Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Famotidine for Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Famotidine for Injection Average Price by Region (2021-2032)
  • 4.2 North America Famotidine for Injection Consumption Value (2021-2032)
  • 4.3 Europe Famotidine for Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Famotidine for Injection Consumption Value (2021-2032)
  • 4.5 South America Famotidine for Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Famotidine for Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Famotidine for Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Famotidine for Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Famotidine for Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Famotidine for Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Famotidine for Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Famotidine for Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Famotidine for Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Famotidine for Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Famotidine for Injection Market Size by Country
    • 7.3.1 North America Famotidine for Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Famotidine for Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Famotidine for Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Famotidine for Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Famotidine for Injection Market Size by Country
    • 8.3.1 Europe Famotidine for Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Famotidine for Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Famotidine for Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Famotidine for Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Famotidine for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Famotidine for Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Famotidine for Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Famotidine for Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Famotidine for Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Famotidine for Injection Market Size by Country
    • 10.3.1 South America Famotidine for Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Famotidine for Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Famotidine for Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Famotidine for Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Famotidine for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Famotidine for Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Famotidine for Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Famotidine for Injection Market Drivers
  • 12.2 Famotidine for Injection Market Restraints
  • 12.3 Famotidine for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Famotidine for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Famotidine for Injection
  • 13.3 Famotidine for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Famotidine for Injection Typical Distributors
  • 14.3 Famotidine for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Famotidine for Injection. Industry analysis & Market Report on Famotidine for Injection is a syndicated market report, published as Global Famotidine for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Famotidine for Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report